John Raplee, Jr. v. United States

842 F.3d 328, 2016 U.S. App. LEXIS 20945, 2016 WL 6871904
Court of Appeals for the Fourth Circuit·Decided November 22, 2016·No. 14-1217·Published·Cited by 88 cases

Opinion

Affirmed by published opinion. Judge MOTZ wrote the opinion, in which Judge NIEMEYER and Senior Judge DAVIS joined.

DIANA GRIBBON MOTZ, Circuit Judge:

John Raplee challenges the dismissal of his Federal Tort Claims Act (“FTCA”) complaint as untimely. In compliance with state law, Raplee initially filed a medical malpractice claim with Maryland’s alternative dispute resolution agency. Although he filed with the state agency within the FTCA’s limitations period, he did not file a complaint in federal court until well after that period had passed. Raplee contends that by filing a required state administrative claim, an “action is begun” for the purposes of the FTCA’s limitations period. 28 U.S.C. § 2401(b) (2012). Alternatively, he asserts that equitable tolling principles excuse his failure to comply with the limitations period. Because an “action is begun” under the FTCA only by filing a civil action in federal district court, Raplee’s claim was untimely. Further, he has not demonstrated any extraordinary circumstances warranting equitable tolling. Accordingly, we affirm the judgment of the district court.

I.

In September 2006, Raplee underwent surgery at the National Institutes of Health, an operating division of the United States Department of Health and Human Services (“HHS”). Raplee alleges that the surgeons “negligently positioned]” him while he was under anesthesia, resulting in permanent damage to the muscles and nerves in his left foot.

The FTCA renders the United States liable for the torts of its employees, including the surgeons in this case, “in the same manner and to the same extent as a private individual under like circumstances.” 28 U.S.C. § 2674. The FTCA requires a plaintiff pursuing a tort claim to follow a multi-step process. First, a plaintiff must file his claim with the appropriate federal agency, which then has the power to settle or deny it. 28 U-S.C. §§ 2401(b), 2676(a). The plaintiff may file a civil action against the United States only if the agency has denied the claim. 28 U.S.C. § 2675(a).

In November 2006, Raplee retained the law firm Ashcraft & Gerel, LLP to represent him in his medical malpractice claim against the United States. On September 16, 2008, Ashcraft & Gerel, through Martin Trpis, filed Raplee’s claim with HHS.

Trpis had left Ashcraft & Gerel by May 2010 while Raplee’s claim was still under administrative review at HHS. Although lawyers from the firm continued to represent Raplee, no one notified HHS of Trpis’s departure, and no other attorney from Ashcraft & Gerel filed an appearance with HHS.

On June 19, 2012, HHS mailed its notice of final denial by certified letter to Trpis at Ashcraft & Gerel. Section 2401(b) of the FTCA bars any tort claim against the United States unless the “action is begun within six months” after the federal agency mails notice of its denial of the claim. 28 U.S.C. § 2401(b). Therefore, Raplee had until December 19, 2012 to begin an action pursuant to the FTCÁ.

The letter HHS sent to Trpis at Ash-craft & Gerel was returned to HHS as undeliverable. The envelope containing the *331 letter was stamped “Returned to Sender” with a handwritten note explaining that Trpis was “no longer at this company.” HHS confirmed that it had sent the letter to the correct address, but it made no further attempt to send notice of its denial; The record contains no evidence that Ra-plee, Trpis, or anyone else inquired as to the status of Raplee’s claim.

Because the FTCA merely waives sovereign immunity to make the United States amenable to a state tort suit, the substantive law of the state where the tort occurred determines the liability of the United States. 28 U.S.C. § 1346(b)(1); see, e.g., Levin v. United States, — U.S. —, 133 S.Ct. 1224, 1228, 185 L.Ed.2d 343 (2013). Accordingly, as the parties agree, Maryland plaintiffs wishing to bring medical malpractice claims against the United States under the FTCA must comply with Maryland’s pre-filing requirements.

On November 8, 2012, Raplee, represented by an Ashcraft & Gerel lawyer (but not Trpis), filed a claim with Maryland’s Health Care Alternative Dispute Resolution Office. Under Maryland law, a plaintiff must submit a medical malpractice claim to this state agency before filing the claim in court. Md. Code Ann., Cts. & Jud. Proc. § 3-2A-02(a), -04(a)(l)(i) (West 2016). A plaintiff must then submit an expert report certifying that the claim is meritorious within ninety days. Id. § 3-2A-04(b)(l)(i)(l). Once a claimant has submitted ah expert report, he may waive arbitration and proceed to court. Id. § 3-2A-06B(a).

Although Raplee filed his initial claim with the Maryland - agency in November 2012—approximately one month before the FTCA filing deadline in December 2012— he did not file his expert report until February 2013. And he did not waive arbitration until March 2013. Raplee finally filed a complaint with the federal district court on May 3, 2013—nearly five months after expiration of his time to begin an action under § 2401(b).

The United States moved to dismiss Ra-plee’s claim for lack of subject matter jurisdiction. The district court granted the motion because, at the time, we considered the FTCA’s limitations period to be jurisdictional, See, e.g., Gould v. U.S. Dep’t of Health & Human Servs., 905 F.2d 738, 741-42 (4th Cir. 1990) (en banc). On appeal, we held the case in abeyance while the Supreme Court resolved that very issue. In United States v. Kwai Fun Wong, — U.S. —, 135 S.Ct. 1625, 1629, 191 L.Ed.2d 533 (2015), the Court held that the FTCA’s limitations period is not a jurisdictional rule but a claims-processing rule that allows for equitable tolling. In light of this decision, we remahdéd Ra-plee’s case so that the district court could decide whether Raplee was entitled to equitable tolling.' The district court concluded that he was not, reasoning that Raplee failed to show that extraordinary circumstances had prevented him from filing in a timely manner.

On appeal, Raplee contends that his claim was timely because, by filing his claim with the state agency, an “action [was] begun” under § 2401(b) of the FTCA. He also contends that, even if his claim was untimely, he is entitled to equitable tolling. We consider these arguments in turn. ,.

II.

In order to determine whether Ra-plee’s claim was ■ timely, we -must decide when an , “action is begun” -under § 2401(b). We review questions of statutory interpretation de novo. Stone v. Instrumentation Lab. Co., 591 F.3d 239, 242-43 (4th Cir. 2009).

Free access — add to your briefcase to read the full text and ask questions with AI

John Raplee, Jr. v. United States, 842 F.3d 328, 2016 U.S. App. LEXIS 20945, 2016 WL 6871904 (4th Cir. 2016).

842 F.3d 328 (John Raplee, Jr. v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related